TY - JOUR
T1 - Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis
AU - van Daalen, Emma E
AU - Wester Trejo, Maria A C
AU - Göçeroğlu, Arda
AU - Ferrario, Franco
AU - Joh, Kensuke
AU - Noël, Laure-Hélène
AU - Ogawa, Yayoi
AU - Wilhelmus, Suzanne
AU - Ball, Miriam J
AU - Honsova, Eva
AU - Hruskova, Zdenka
AU - Kain, Renate
AU - Kimura, Tomoyoshi
AU - Kollar, Marek
AU - Kronbichler, Andreas
AU - Lindhard, Kristine
AU - Puéchal, Xavier
AU - Salvatore, Steven
AU - Szpirt, Wladimir
AU - Takizawa, Hideki
AU - Tesar, Vladimir
AU - Berden, Annelies E
AU - Dekkers, Olaf M
AU - Hagen, E Christiaan
AU - Oosting, Jan
AU - Rahmattulla, Chinar
AU - Wolterbeek, Ron
AU - Bos, Willem Jan
AU - Bruijn, Jan A
AU - Bajema, Ingeborg M
N1 - Copyright © 2020 by the American Society of Nephrology.
PY - 2020/8/7
Y1 - 2020/8/7
N2 - BACKGROUND AND OBJECTIVES: The histopathologic classification for ANCA-associated GN distinguishes four classes on the basis of patterns of injury. In the original validation study, these classes were ordered by severity of kidney function loss as follows: focal, crescentic, mixed, and sclerotic. Subsequent validation studies disagreed on outcomes in the crescentic and mixed classes. This study, driven by the original investigators, provides several analyses in order to determine the current position of the histopathologic classification of ANCA-associated GN.DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A validation study was performed with newly collected data from 145 patients from ten centers worldwide, including an analysis of interobserver agreement on the histopathologic evaluation of the kidney biopsies. This study also included a meta-analysis on previous validation studies and a validation of the recently proposed ANCA kidney risk score.RESULTS: The validation study showed that kidney failure at 10-year follow-up was significantly different between the histopathologic classes (P<0.001). Kidney failure at 10-year follow-up was 14% in the crescentic class versus 20% in the mixed class (P=0.98). In the meta-analysis, no significant difference in kidney failure was also observed when crescentic class was compared with mixed class (relative risk, 1.15; 95% confidence interval, 0.94 to 1.41). When we applied the ANCA kidney risk score to our cohort, kidney survival at 3 years was 100%, 96%, and 77% in the low-, medium-, and high-risk groups, respectively (P<0.001). These survival percentages are higher compared with the percentages in the original study.CONCLUSIONS: The crescentic and mixed classes seem to have a similar prognosis, also after adjusting for differences in patient populations, treatment, and interobserver agreement. However, at this stage, we are not inclined to merge the crescentic and mixed classes because the reported confidence intervals do not exclude important differences in prognosis and because an important histopathologic distinction would be lost.
AB - BACKGROUND AND OBJECTIVES: The histopathologic classification for ANCA-associated GN distinguishes four classes on the basis of patterns of injury. In the original validation study, these classes were ordered by severity of kidney function loss as follows: focal, crescentic, mixed, and sclerotic. Subsequent validation studies disagreed on outcomes in the crescentic and mixed classes. This study, driven by the original investigators, provides several analyses in order to determine the current position of the histopathologic classification of ANCA-associated GN.DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A validation study was performed with newly collected data from 145 patients from ten centers worldwide, including an analysis of interobserver agreement on the histopathologic evaluation of the kidney biopsies. This study also included a meta-analysis on previous validation studies and a validation of the recently proposed ANCA kidney risk score.RESULTS: The validation study showed that kidney failure at 10-year follow-up was significantly different between the histopathologic classes (P<0.001). Kidney failure at 10-year follow-up was 14% in the crescentic class versus 20% in the mixed class (P=0.98). In the meta-analysis, no significant difference in kidney failure was also observed when crescentic class was compared with mixed class (relative risk, 1.15; 95% confidence interval, 0.94 to 1.41). When we applied the ANCA kidney risk score to our cohort, kidney survival at 3 years was 100%, 96%, and 77% in the low-, medium-, and high-risk groups, respectively (P<0.001). These survival percentages are higher compared with the percentages in the original study.CONCLUSIONS: The crescentic and mixed classes seem to have a similar prognosis, also after adjusting for differences in patient populations, treatment, and interobserver agreement. However, at this stage, we are not inclined to merge the crescentic and mixed classes because the reported confidence intervals do not exclude important differences in prognosis and because an important histopathologic distinction would be lost.
UR - http://www.scopus.com/inward/record.url?scp=85089301042&partnerID=8YFLogxK
U2 - 10.2215/CJN.14561119
DO - 10.2215/CJN.14561119
M3 - Journal article
C2 - 32723805
SN - 1555-9041
VL - 15
SP - 1103
EP - 1111
JO - Clinical journal of the American Society of Nephrology : CJASN
JF - Clinical journal of the American Society of Nephrology : CJASN
IS - 8
ER -